Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$191.17 - $325.63 $26.1 Million - $44.4 Million
136,410 Added 2236.23%
142,510 $46.4 Million
Q4 2023

Jul 16, 2024

SELL
$160.99 - $215.69 $22 Million - $29.4 Million
-136,410 Reduced 95.72%
6,100 $1.16 Million
Q3 2023

Nov 14, 2023

SELL
$194.33 - $283.97 $1.19 Million - $1.73 Million
-6,100 Reduced 50.0%
6,100 $1.21 Million
Q2 2023

Aug 14, 2023

SELL
$223.05 - $302.68 $3.26 Million - $4.42 Million
-14,600 Reduced 54.48%
12,200 $3.48 Million
Q1 2023

May 15, 2023

BUY
$175.41 - $217.92 $1.96 Million - $2.44 Million
11,200 Added 71.79%
26,800 $5.81 Million
Q3 2022

Feb 14, 2023

BUY
$195.21 - $310.53 $858,924 - $1.37 Million
4,400 Added 39.29%
15,600 $4.34 Million
Q3 2022

Nov 14, 2022

BUY
$195.21 - $310.53 $858,924 - $1.37 Million
4,400 Added 39.29%
15,600 $4.34 Million
Q2 2022

Feb 14, 2023

BUY
$115.91 - $214.48 $822,961 - $1.52 Million
7,100 Added 173.17%
11,200 $2.14 Million
Q2 2022

Aug 15, 2022

BUY
$115.91 - $214.48 $822,961 - $1.52 Million
7,100 Added 173.17%
11,200 $2.14 Million
Q1 2022

Feb 14, 2023

SELL
$127.96 - $207.36 $1.47 Million - $2.38 Million
-11,500 Reduced 73.72%
4,100 $850,000
Q1 2022

May 13, 2022

BUY
$127.96 - $207.36 $524,636 - $850,176
4,100 New
4,100 $850,000
Q1 2021

May 14, 2021

SELL
$92.73 - $142.05 $5.55 Million - $8.49 Million
-59,800 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$67.44 - $103.72 $3.57 Million - $5.49 Million
-52,900 Reduced 46.94%
59,800 $6.2 Million
Q3 2020

Nov 13, 2020

SELL
$42.79 - $75.8 $971,333 - $1.72 Million
-22,700 Reduced 16.77%
112,700 $8.54 Million
Q2 2020

Aug 14, 2020

BUY
$27.25 - $47.53 $48,341 - $84,318
1,774 Added 1.33%
135,400 $6.41 Million
Q1 2020

May 15, 2020

BUY
$23.16 - $47.74 $3.09 Million - $6.38 Million
133,626 New
133,626 $4.43 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.